Painchek Simple Investment Thesis, page-17

After drafting a email with several questions and sending it to Painchek last week, a received a email back from our CEO.
Although I cannot disclose the contents, I can tell you it has lifted my spirits considerably.
Submission to FDA is to be completed comprehensively so that it has no holes which could delay approval.That being the case, FDA should have no issues,questions etc which adds time to approval.
These are not his words, but I have a feeling submission
is close now and fingers crossed, approval could be delivered before Christmas.
Keeping the faith.
Cheers Holders.
DYOR. Aimo